Stocks · Health care · Pharmaceutical Preparations

GENELUX Corp

GNLX Clue Score27

United States Fiscal year ends December CIK 0001231457 Results filed 25 Mar 2025

Add to watchlist

What the insiders did Net selling

By person

12 insiders · 28 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Thomas Zindrick

President and CEO

—

$148.23K (6)

−$148.23K

1,423,338

3.15%

$2.86M

+456.2%

John Thomas

Director

—

$108.77K (3) scheduled

−$108.77K

501,193

1.11%

$1.01M

−0.9%

Joseph Cappello

Chief Technical Officer

—

$40.62K (6)

−$40.62K

317,812

0.7024%

$639.22K

+1,417%

Yong Yu

Chief Scientific Officer

—

$39.14K (6)

−$39.14K

258,020

0.5703%

$518.96K

+1,404%

John W Smither

Director

—

$34.90K (1)

−$34.90K

91,403

0.2020%

$183.84K

+73.4%

Ralph Smalling

Head of Regulatory

—

$5.42K (6)

−$5.42K

67,611

0.1494%

$135.99K

+259.0%

Matthew Pulisic

Chief Financial Officer

—

—

—

278,906

0.6164%

$560.96K

—

Eric Groen

General Counsel

—

—

—

233,957

0.5171%

$470.56K

—

Mary Mirabelli

Director

—

—

—

102,693

0.2270%

$206.55K

+97.5%

James L Tyree

Director

—

—

—

96,483

0.2132%

$194.06K

+95.9%

Lourie S. Zak

Chief Financial Officer

—

—

—

82,452

0.1822%

$165.84K

+92.2%

Sean Ryder

General Counsel

—

—

—

47,621

0.1053%

$95.78K

+145.6%